The Cardiac Benefit of Androgen Replacement in Hypogonadal Males with Coronary Artery Disease Following Successful Percutaneous Coronary Intervention (PCI)

ID Number 06-1081

Principal Investigator(s)
Mary A McLaughlin

Department(s) or Division(s)

Research Entity
The Zena and Michael A. Wiener Cardiovascular Institute


This is a randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of testosterone supplementation in hypogonadal men with coronary artery disease (narrowing of the arteries giving blood to the heart) following successful percutaneous coronary intervention (PCI),(procedure wherein blockage or narrowed artery is being dilated or stretched to allow better flow of blood in the heart).

Contact Information
Lourdes Campos-Grundvig, RN, MS
(212) 241-3141

Recruiting Patients: Yes